• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

MEDICA 2022 and COMPAMED 2022: International health industry meet-up in Düsseldorf

, 9 November 2022/in E-News, Events /by panglobal

Notable increase in participation – accompanying programme with many highlights and many prominent visitors Next week sees the return of the date marked in extra thick outline in many yearly calendars of the international health and medical technology industry: From Monday to Thursday (14 to 17 November 2022), the international leading medical trade fair MEDICA […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/MEDICA4.jpeg 427 640 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-09 15:32:242022-11-09 15:32:24MEDICA 2022 and COMPAMED 2022: International health industry meet-up in Düsseldorf

Global Fund private sector partners pledge record levels of support to End AIDS, TB, Malaria and strengthen systems for health

, 4 November 2022/in E-News /by panglobal

At the Global Fund’s Seventh Replenishment Conference, private sector partners committed more funding, in-kind support and catalytic investment than ever before to end the three deadly diseases. This commitment and strong call to action for other partners to join in was led by the Bill & Melinda Gates Foundation, who committed a record US$912 million, […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/global-fund.png 530 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 18:19:072022-11-04 18:21:49Global Fund private sector partners pledge record levels of support to End AIDS, TB, Malaria and strengthen systems for health

Mapping out the future of health for WHO European Region

, 4 November 2022/in E-News /by panglobal

After holding its most important annual gathering online amid the pandemic for 2 years in a row, WHO/Europe convened the 72nd session of its Regional Committee (RC72) on 12–14 September 2022 in Israel. All 53 Member States from across Europe and central Asia were invited, along with a variety of health partners. In all, some […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/WHO-Europe-1.png 369 600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 18:14:562022-11-04 18:14:56Mapping out the future of health for WHO European Region

Healthcare researchers warned to be wary of misusing AI

, 4 November 2022/in E-News /by panglobal

An international team of researchers, writing in the journal Nature Medicine, advises that strong care needs to be taken not to misuse or overuse machine learning (ML) in healthcare research.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/Schermafbeelding-2022-10-31-om-12.08.59-e1667585181161.png 453 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 18:08:392022-11-04 18:08:39Healthcare researchers warned to be wary of misusing AI

Philips Foundation, RAD-AID International embark on a multi-year cross-continental partnership to increase access to ultrasound

, 4 November 2022/in E-News /by panglobal

Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, together with Philips and RAD-AID International, have announced a multi-year cross-continental partnership to promote access to diagnostic ultrasound services in ten countries.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/philips-rad-aid-partnership.jpg 1080 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:44:022022-11-04 15:44:02Philips Foundation, RAD-AID International embark on a multi-year cross-continental partnership to increase access to ultrasound

Aero Healthcare report 47% increase in UK defibrillator sales

, 4 November 2022/in E-News /by panglobal

UK first aid wholesalers, Aero Healthcare, have reported that the AED (Automated External Defibrillator) market has continued to experience strong year on year growth in the United Kingdom, with the company recording a 47% increase in AED sales since 2020 alongside a global market growth of 35%. The 47% increase equates to more than 10,000 […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/Aero_-AEDS.jpg 659 1557 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:41:182022-11-04 15:41:18Aero Healthcare report 47% increase in UK defibrillator sales

Ceryx Medical partners with Osypka Medical to test bionic pacemaker

, 4 November 2022/in E-News /by panglobal

A Welsh MedTech company is taking next steps towards launching its unique technology, after securing a partnership with a leading medical devices company.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/shutterstock_1855544260-scaled-e1680869370262.jpg 571 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:39:132022-11-04 15:39:13Ceryx Medical partners with Osypka Medical to test bionic pacemaker

Inceptua Early Access and Sentynl Therapeutics launch Early Access Programme for Nulibry for paediatric patients with Molybdenum Cofactor Deficiency Type A

, 4 November 2022/in E-News /by panglobal

Inceptua Early Access and Sentynl Therapeutics, a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases have entered into a partnership to make Sentynl’s Nulibry available via an Early Access Program for eligible patients with molyb- denum cofactor deficiency (MoCD) Type A.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/Inceptua_Logo.jpg 785 1498 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:36:402022-11-04 15:36:40Inceptua Early Access and Sentynl Therapeutics launch Early Access Programme for Nulibry for paediatric patients with Molybdenum Cofactor Deficiency Type A

Cambridge Cognition aims to become major player in fast- growing $7.8 billion virtual clinical trials market with acquisition of eClinicalHealth

, 4 November 2022/in E-News /by panglobal

Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly and is now valued at US$7.8 billion with a projected growth of 14% per annum [1]. Cambridge Cognition is an active player in the central nervous system (CNS) market, supplying digital solutions to assess brain health. Now, in a major strategic move […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/shutterstock_1650398500-scaled-e1680869453831.jpg 600 1283 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:33:152022-11-04 15:33:42Cambridge Cognition aims to become major player in fast- growing $7.8 billion virtual clinical trials market with acquisition of eClinicalHealth

BD, Biocorp collaborate to bring connectivity, trace- ability to self-administered injectable drugs

, 4 November 2022/in E-News /by panglobal

Becton, Dickinson and Company (BD), a leading global medical technology company, and Biocorp, a medical device and delivery systems manufacturer based in France, have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/11/BD_logo.jpg 594 1438 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-11-04 15:23:172022-11-04 15:27:18BD, Biocorp collaborate to bring connectivity, trace- ability to self-administered injectable drugs
Page 36 of 231«‹3435363738›»

Latest issue of International Hospital

April 2024

3 July 2025

EEG-powered brain computer interface enables finger-level robotic hand control

2 July 2025

Scientists identify ‘traumome’ targets for rapid emergency trauma treatment

1 July 2025

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription